Our Best Trade Of 2026

It is so valuable, I’ve decided to make sure that every single one of our subscribers has access to it, completely for free.

By entering your name and email below, you will receive a report detailing what Erez Kalir is calling a “thoughtful speculation” around a specific biotech company, one that could easily return investors up to 50%, or potentially even more, if this company is acquired as we predict.

We only ask that if this deal materializes as we expect, that is, if there’s around a 50% windfall gain from this deal, then you will subscribe to Erez’s work, either as a subscriber to Tech Frontiers or by joining our partnership through our Partner Pass subscription.

We’re confident enough in the value of our work to show it to you upfront. And if we’re right, we’ll only ask you for a subscription in return. You won’t find a better deal in financial research.